Published in J Biol Chem on September 14, 2015
Therapies for Prevention and Treatment of Alzheimer's Disease. Biomed Res Int (2016) 0.77
Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism. Proc Natl Acad Sci U S A (2017) 0.75
How membrane dysfunction influences neuronal survival pathways in sphingolipid storage disorders. J Neurosci Res (2016) 0.75
Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19
Autophagy: renovation of cells and tissues. Cell (2011) 11.59
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med (1995) 10.91
The MAPK signaling cascade. FASEB J (1995) 10.81
Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem (2003) 8.83
Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 8.14
The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med (2006) 5.51
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol (2011) 4.76
Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies. Diabetologia (2005) 4.19
Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA (2002) 4.18
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci U S A (2005) 3.75
Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol (2004) 3.67
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest (2012) 3.65
Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res (2004) 3.30
Cognition and diabetes: a lifespan perspective. Lancet Neurol (2008) 2.96
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry (2009) 2.57
Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol (2004) 2.57
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. J Clin Invest (2012) 2.33
Cell cycle-dependent activation of Ras. Curr Biol (1996) 2.26
Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis. Ann Neurol (2007) 2.18
The role of insulin receptor signaling in the brain. Trends Endocrinol Metab (2005) 2.01
OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation. Science (2005) 1.99
Probing red cell membrane cholesterol movement with cyclodextrin. Biophys J (2002) 1.80
Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. Int J Biochem Cell Biol (2004) 1.74
Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol (2004) 1.74
Cholesterol in Alzheimer's disease. Lancet Neurol (2005) 1.72
The ULK1 complex: sensing nutrient signals for autophagy activation. Autophagy (2013) 1.71
The SNARE proteins SNAP-25 and SNAP-23 display different affinities for lipid rafts in PC12 cells. Regulation by distinct cysteine-rich domains. J Biol Chem (2004) 1.35
Preparing synthetic Aβ in different aggregation states. Methods Mol Biol (2011) 1.26
Regulation of amyloid precursor protein processing by the Beclin 1 complex. PLoS One (2010) 1.22
Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab (2010) 1.19
Insulin resistance in the nervous system. Trends Endocrinol Metab (2012) 1.18
Cholesterol reduction impairs exocytosis of synaptic vesicles. J Cell Sci (2010) 1.18
Insulin action in brain regulates systemic metabolism and brain function. Diabetes (2014) 1.18
Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin. Neuroscience (2006) 1.13
Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes. Biochemistry (1994) 1.10
Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacol Biochem Behav (2002) 1.07
Intranasal insulin as a therapeutic option in the treatment of cognitive impairments. Exp Gerontol (2010) 1.01
Autophagy: a double-edged sword in Alzheimer's disease. J Biosci (2012) 1.00
Insulin as an in vivo growth factor. Exp Neurol (2004) 0.99
Protein isoprenylation in biology and disease: general overview and perspectives from studies with genetically engineered animals. Front Biosci (2007) 0.96
Autophagic neuron death. Methods Enzymol (2009) 0.88
Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function. PLoS Biol (2013) 0.86
Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes. Biochim Biophys Acta (2010) 0.85
Insulin signaling in retinal neurons is regulated within cholesterol-enriched membrane microdomains. Am J Physiol Endocrinol Metab (2011) 0.84
Prescription of lipophilic statins to Alzheimer's disease patients: some controversies to consider. Neurol Sci (2010) 0.84
Roles of cholesterol in vesicle fusion and motion. Biophys J (2009) 0.84
Lovastatin inhibits the stimulation of mitogen-activated protein kinase by insulin in HIRcB fibroblasts. Arch Biochem Biophys (1996) 0.82
Dominant negative alpha-subunit of FTase inhibits effects of insulin and IGF-I in MCF-7 cells. Biochem Biophys Res Commun (2002) 0.80